首页> 外文期刊>Journal of Pharmacological and Toxicological Methods >Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level.
【24h】

Methodologies to study the induction of rat hepatic and intestinal cytochrome P450 3A at the mRNA, protein, and catalytic activity level.

机译:在mRNA,蛋白质和催化活性水平研究诱导大鼠肝和肠细胞色素P450 3A的方法。

获取原文
获取原文并翻译 | 示例
       

摘要

Studies were conducted to characterize assays for the isolation and quantitation of rat cytochrome P450 (CYP) 3A isoforms from hepatic and intestinal tissues. Isolated intestinal microsomes were analyzed for their alkaline phosphatase activity and CYP 3A immunoreactivity. The involvement of CYP 3A in the in vitro hydroxylation of midazolam (MDZ) was also evaluated using isoform specific chemical and antibody inhibitors. The effect of glycerol (a common constituent of the microsomal reconstitution buffer) concentration on in vitro MDZ hydroxylation was also investigated. Additionally, to verify that the intestinal preparation was adequate for use in studies investigating the induction of CYP3A at the MRNA, protein, and catalytic activity within a single animal, a separate induction study was carried out with the CYP 3A inducer dexamethasone (DEX). A reverse transcription-polymerase chain reaction (RT-PCR) assay and a quantitative Western blotting method were used to reliably detect differences in CYP 3A mRNA and immunoreactivity between DEX- and vehicle (VH)-treated tissues. The in vitro hydroxylation of MDZ evaluated CYP 3A catalytic activity and identified increases in CYP 3A activity caused by DEX in comparison to VH. Collectively, these described techniques provide an experimental model to study xenobiotic induction of rat hepatic and intestinal CYP 3A from the molecular to the catalytic level in individual rats without the need for pooling of tissue.
机译:进行了研究以表征用于从肝和肠组织中分离和定量大鼠细胞色素P450(CYP)3A亚型的分析方法。分析分离的肠微粒体的碱性磷酸酶活性和CYP 3A免疫反应性。还使用同工型特异性化学和抗体抑制剂评估了CYP 3A在咪达唑仑(MDZ)体外羟基化中的作用。还研究了甘油(微粒体重建缓冲液的常见成分)浓度对体外MDZ羟基化的影响。此外,为验证肠道制剂是否适合用于研究CYP3A对MRNA,蛋白质和催化活性的影响的研究,对一只动物进行了单独的诱导研究,使用CYP3A诱导剂地塞米松(DEX)进行了单独的诱导研究。逆转录-聚合酶链反应(RT-PCR)测定法和定量Western印迹法用于可靠地检测CYP 3A mRNA的差异以及经DEX和媒介物(VH)处理的组织之间的免疫反应性。 MDZ的体外羟基化可评估CYP 3A的催化活性,并确定与VH相比,由DEX引起的CYP 3A活性增加。总的来说,这些描述的技术提供了实验模型,以研究异种生物诱导大鼠肝和肠中CYP 3A从分子水平到催化水平的水平,而无需合并组织。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号